The figure for the most recent quarter came in above the FactSet analyst projection of 88.5%. There was also bad news for ...
The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback